Treatment of acute coronary syndrome with cardiac medications and early-invasive approaches is underutilized in elderly patients (age >= 65 years) despite their likelihood to benefit.
Highlights the underutilization of evidence-based ACS therapies in elderly patients despite their high potential for benefit.
The spectrum of acute coronary syndrome (ACS) including unstable angina, non-ST-elevation myocardial infarction and ST-elevation myocardial infarction accounts for increasing numbers of deaths among persons age > or = 65 years in the US. This is important given demographic changes involving falling birth rates and increasing life expectancy. Elderly patients are likely to benefit the most from treatment of ACS, even though community practice still demonstrates less use of cardiac medications as an early-invasive approach among this population.
Shanmugasundaram et al. (Sun,) conducted a review in Acute coronary syndrome. Cardiac medications and early-invasive approach was evaluated. Treatment of acute coronary syndrome with cardiac medications and early-invasive approaches is underutilized in elderly patients (age >= 65 years) despite their likelihood to benefit.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: